MiR-29a/b enhances cell migration and invasion in nasopharyngeal carcinoma progression by regulating SPARC and COL3A1 gene expression

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Qiu, Feifei ^a   Sun, Rui ^b   Deng, Ning ^c   Guo, Tianyu ^a   Cao, Yange ^a   Yu, Ying ^a   Wang, Xuejun ^a   Zou, Bingcheng ^a   Zhang, Songmei ^a   Jing, Tao ^a   Ling, Tao ^a   Xie, Jun ^d   Zhang, Qing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c JINAN UNIVERSITY   (China)

^d AGRO ENVIRONMENTAL PROTECTION INSTITUTE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 29A; MICRORNA 29B; OSTEONECTIN; COL3A1 PROTEIN, HUMAN; COLLAGEN TYPE 3; LUCIFERASE; MICRORNA; MIRN29 MICRORNA, HUMAN; SPARC PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COL3A1 GENE; COL4A1 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; NASOPHARYNX CARCINOMA; NID1 GENE; NID2 GENE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK; SPARC GENE; SURVIVAL TIME; UPREGULATION; ADOLESCENT; CASE CONTROL STUDY; CELL MOTION; DISEASE COURSE; G1 PHASE CELL CYCLE CHECKPOINT; GENETICS; HEK293 CELL LINE; METABOLISM; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; PATHOLOGY; PROGNOSIS; REPORTER GENE; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; TUMOR CELL LINE; TUMOR INVASION;

HUMAN HERPESVIRUS 4;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN TYPE III; DISEASE PROGRESSION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HEK293 CELLS; HUMANS; LUCIFERASES; MICRORNAS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEONECTIN; PROGNOSIS; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS;

EID: 84925428057     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120969     Document Type: Article

References (63)

1. Lin J-C, Jan J-S, Hsu C-Y, Liang W-M, Jiang R-S, Wang W-Y. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. Journal of clinical oncology. 2003; 21(4):631-7. PMID: 12586799
2. Luo J, Chia KS, Chia SE, Reilly M, Tan CS, Ye W. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. European journal of epidemiology. 2007; 22(8):513-21. PMID: 17594525
3. Khanfir A, Frikha M, Ghorbel A, Drira M, Daoud J. Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer/Radiothrapie. 2007; 11(8):461-4. PMID: 17689126
4. Wong T-S, Man O-Y, Tsang C-M, Tsao S-W, Tsang RK-Y, Chan JY-W, et al. MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Journal of cancer research and clinical oncology. 2011; 137(3):415-22. doi: 10.1007/s00432-010-0898-4 PMID: 20440510
5. Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Molecular cell. 2008; 29(1):1-7. doi: 10.1016/j.molcel.2007.12.010 PMID: 18206964
6. Nilsen TW. Mechanisms of microRNA-mediated gene regulation in animal cells. TRENDS in Genetics. 2007; 23(5):243-9. PMID: 17368621
7. Liu T, Papagiannakopoulos T, Puskar K, Qi S, Santiago F, Clay W, et al. Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS One. 2007; 2(8):e804. PMID: 17726534
8. Wang L, Oberg AL, Asmann YW, Sicotte H, McDonnell SK, Riska SM, et al. Genome-wide transcriptional profiling reveals microRNA-correlated genes and biological processes in human lymphoblastoid cell lines. PLoS One. 2009; 4(6):e5878. doi: 10.1371/journal.pone.0005878 PMID: 19517021
9. Wang Y-P, Li K-B. Correlation of expression profiles between microRNAs and mRNA targets using NCI-60 data. BMC genomics. 2009; 10(1):218.
10. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A. 2008; 105(15):5874-8. Epub 2008/04/09. doi: 10.1073/pnas.0801130105 PMID: 18390668
11. Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(7):2257-61. PMID: 16461460
12. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annual review of medicine. 2009; 60:167-79. doi: 10.1146/annurev.med.59.053006.104707 PMID: 19630570
13. Wang Y, Zhang X, Li H, Yu J, Ren X. The role of miRNA-29 family in cancer. European journal of cell biology. 2013; 92(3):123-8. doi: 10.1016/j.ejcb.2012.11.004 PMID: 23357522
14. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences. 2007; 104(40):15805-10. PMID: 17890317
15. Park SY, Lee JH, Ha M, Nam JW, Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol. 2009; 16(1):23-9. Epub 2008/12/17. doi: 10.1038/nsmb.1533 PMID: 19079265
16. Van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proceedings of the National Academy of Sciences. 2008; 105(35):13027-32. doi: 10.1073/pnas.0805038105 PMID: 18723672
17. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. Journal of Biological Chemistry. 2009; 284 (23):15676-84. doi: 10.1074/jbc.M809787200 PMID: 19342382
18. Cortez MA, Nicoloso MS, Shimizu M, Rossi S, Gopisetty G, Molina JR, et al. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes, Chromosomes and Cancer. 2010; 49(11):981-90. doi: 10.1002/gcc.20808 PMID: 20665731
19. Amodio N, Leotta M, Bellizzi D, Di Martino MT, D'Aquila P, Lionetti M, et al. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget. 2012; 3(10):1246-58. PMID: 23100393
20. Luna C, Li G, Qiu J, Epstein DL, Gonzalez P. Role of miR-29b on the regulation of the extracellular matrix in human trabecular meshwork cells under chronic oxidative stress. Molecular vision. 2009; 15:2488. PMID: 19956414
21. Brekken RA, Sage EH. SPARC, a matricellular protein: at the crossroads of cell-matrix communication:[ Matrix Biology (2000) 569-580]. Matrix Biology. 2001; 19(8):815-27.
22. Kupprion C, Motamed K, Sage EH. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. Journal of Biological Chemistry. 1998; 273(45):29635-40. PMID: 9792673
23. Raines EW, Lane TF, Iruela-Arispe ML, Ross R, Sage EH. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A. 1992; 89(4):1281-5. Epub 1992/02/15. PMID: 1311092
24. Ryschich E, Khamidjanov A, Kerkadze V, Buchler MW, Zöller M, Schmidt J. Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. Pancreas. 2009; 38(7):804-10. doi: 10.1097/MPA.0b013e3181b9dfda PMID: 19893454
25. Provenzano PP, Eliceiri KW, Campbell JM, Inman DR, White JG, Keely PJ. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC medicine. 2006; 4(1):1-15.
26. Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, et al. Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer research. 2006; 66(21):10365-76. Epub 2006/10/26. PMID: 17062557
27. Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Medical Genomics. 2012; 5(1):3.
28. Li T, Chen J-X, Fu X-P, Yang S, Zhang Z, Chen K-H, et al. microRNA expression profiling of nasopharyngeal carcinoma. Oncology reports. 2011; 25(5):1353-63. doi: 10.3892/or.2011.1204 PMID: 21373758
29. Wang H-Y, Sun B-Y, Zhu Z-H, Chang ET, To K-F, Hwang JS, et al. Eight-signature classifier for prediction of nasopharyngeal carcinoma survival. Journal of clinical oncology. 2011; 29(34):4516-25. doi: 10.1200/JCO.2010.33.7741 PMID: 22025164
30. Kapinas K, Kessler CB, Delany AM. miR-29 suppression of osteonectin in osteoblasts: regulation during differentiation and by canonical Wnt signaling. Journal of cellular biochemistry. 2009; 108(1):216-24. doi: 10.1002/jcb.22243 PMID: 19565563
31. Gerson KD, Shearstone JR, Maddula VS, Seligmann BE, Mercurio AM. Integrin beta4 regulates SPARC protein to promote invasion. J Biol Chem. 2012; 287(13):9835-44. Epub 2012/02/07. doi: 10.1074/jbc.M111.317727 PMID: 22308039
32. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proceedings of the National Academy of Sciences. 2007; 104(39):15472-7. PMID: 17875987
33. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo Y-Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell research. 2008; 18(3):350-9. doi: 10.1038/cr.2008.24 PMID: 18270520
34. Huang Q, Gumireddy K, Schrier M, Le Sage C, Nagel R, Nair S, et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nature cell biology. 2008; 10(2):202-10. doi: 10.1038/ncb1681 PMID: 18193036
35. Ramaswamy S, Ross KN, Lander ES, Golub TR. A molecular signature of metastasis in primary solid tumors. Nature genetics. 2003; 33(1):49-54. PMID: 12469122
36. Francki A, Bradshaw AD, Bassuk JA, Howe CC, Couser WG, Sage EH. SPARC regulates the expression of collagen type I and transforming growth factor-β1 in mesangial cells. Journal of Biological Chemistry. 1999; 274(45):32145-52. PMID: 10542250
37. Framson PE, Sage EH. SPARC and tumor growth: where the seed meets the soil? Journal of cellular biochemistry. 2004; 92(4):679-90. PMID: 15211566
38. Huang DY, Lin YT, Jan PS, Hwang YC, Liang ST, Peng Y, et al. Transcription factor SOX-5 enhances nasopharyngeal carcinoma progression by down-regulating SPARC gene expression. The Journal of pathology. 2008; 214(4):445-55. PMID: 18085523
39. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, et al. Using expression profiling data to identify human microRNA targets. Nature methods. 2007; 4(12):1045-9. PMID: 18026111
40. Chen H, Chen G, Chen Y, Liao W, Liu C, Chang K, et al. MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma. British journal of cancer. 2009; 100(6):1002-11. doi: 10.1038/sj.bjc.6604948 PMID: 19293812
41. Xiao-xia L, Rui-ping L, Zi-ming D, Mu-sheng Z, Jian-yong S. Identification of Differentially Expressed MicroRNAs in Nasopharyngeal Carcinoma. JOURNAL OF SUN YAT-SEN UNIVERSITY(MEDICAL SCIENCES). 2007; 28(6):607-12.
42. Sengupta S, Den Boon JA, Chen I-H, Newton MA, Dahl DB, Chen M, et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer research. 2006; 66(16):7999-8006. PMID: 16912175
43. Raija S, Haka-Risku T, Prockop DJ, Tryggvason K. Complete primary structure of the [alpha] 1-chain of human basement membrane (type IV) collagen. FEBS letters. 1987; 225(1-2):188-94. PMID: 3691809
44. Dalgleish R. The Human Collagen Mutation Database 1998. Nucleic Acids Res. 1998; 26(1):253-5. Epub 1998/02/21. PMID: 9399846
45. Steele R, Mott JL, Ray RB. MBP-1 upregulates miR-29b, which represses Mcl-1, collagens, and matrix metalloproteinase-2 in prostate cancer cells. Genes & cancer. 2010; 1(4):381.
46. Wu C, Chung AE, McDonald JA. A novel role for alpha 3 beta 1 integrins in extracellular matrix assembly. J Cell Sci. 1995; 108 (Pt 6):2511-23. Epub 1995/06/01. PMID: 7673365
47. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011; 45(2):287-94. Epub 2010/10/26. doi: 10.1165/rcmb.2010-0323OC PMID: 20971881
48. Kohfeldt E, Sasaki T, Gohring W, Timpl R. Nidogen-2: a new basement membrane protein with diverse binding properties1. Journal of molecular biology. 1998; 282(1):99-109. PMID: 9733643
49. Zhu X-C, Dong Q-Z, Zhang X-F, Deng B, Jia H-L, Ye Q-H, et al. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma. International Journal of Molecular Medicine. 2012; 30(6):1321. doi: 10.3892/ijmm.2012.1140 PMID: 23023935
50. Villarreal G, Oh D-J, Kang MH, Rhee DJ. Coordinated regulation of extracellular matrix synthesis by the microRNA-29 family in the trabecular meshwork. Investigative ophthalmology & visual science. 2011; 52(6):3391-7.
51. Wei H-Y, Liu J-L, Lv B-J, Xing L, Fu S-Y. SPARC modulates expression of extracellular matrix genes in human trabecular meshwork cells. Acta Ophthalmologica. 2012; 90(2):e138-e43. doi: 10.1111/j.1755-3768.2011.02283.x PMID: 22136411
52. Kong G, Zhang J, Zhang S, Shan C, Ye L, Zhang X. Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model. PLoS One. 2011; 6 (5):e19518. doi: 10.1371/journal.pone.0019518 PMID: 21573166
53. Gebeshuber CA, Zatloukal K, Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO reports. 2009; 10(4):400-5. doi: 10.1038/embor.2009.9 PMID: 19247375
54. Wang C, Bian Z, Wei D, Zhang J-g. miR-29b regulates migration of human breast cancer cells. Molecular and cellular biochemistry. 2011; 352(1-2):197-207. doi: 10.1007/s11010-011-0767-8 PMID: 21519924
55. Fang J, Zhou H, Zeng C, Yang J, Liu Y, Huang X, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011; 54 (5):1729-40. doi: 10.1002/hep.24577 PMID: 21793034
56. Muniyappa M, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. European Journal of Cancer. 2009; 45(17):3104-18. doi: 10.1016/j.ejca.2009.09.014 PMID: 19818597
57. Liu N, Tang L-L, Sun Y, Cui R-X, Wang H-Y, Huang B-J, et al. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma. Cancer letters. 2013.
58. Funk SE, Sage EH. The Ca2 (+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proceedings of the National Academy of Sciences. 1991; 88(7):2648-52. PMID: 2011576
59. Sage H, Vernon RB, Funk SE, Everitt EA, Angello J. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+ 2-dependent binding to the extracellular matrix. The Journal of cell biology. 1989; 109(1):341-56. PMID: 2745554
60. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003; 113(6):673-6. PMID: 12809598
61. Yu S-L, Chen H-Y, Chang G-C, Chen C-Y, Chen H-W, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell. 2008; 13(1):48-57. doi: 10.1016/j.ccr.2007.12.008 PMID: 18167339
62. Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, et al. MicroRNA expression, survival, and response to interferon in liver cancer. New England Journal of Medicine. 2009; 361(15):1437-47. doi: 10.1056/NEJMoa0901282 PMID: 19812400
63. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. The lancet oncology. 2010; 11(2):136-46. doi: 10.1016/S1470-2045(09)70343-2 PMID: 20022810